Skip to main content

Table 1 Serum analysis

From: Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity

  

Acute, 24 h, single dose

Chronic, 30 day, daily dose

  

Control

10 mg/kg

100 mg/kg

Control

3 mg/kg

10 mg/kg

  

N = 3

N = 8

N = 8

N = 9

N = 10

N = 9

 

Normal range

Mean

Mean

Mean

Mean

Mean

Mean

Alanine aminotransferase U/L

22–133

30.7

36.1

1282.9***

52.1

43.1

38.4

Aspartate aminotransferase U/L

46–221

63.3

89.5

565.3**

367.0

150.9

236.2

Albumin g/dL

2.6–5.4

2.2

2.3

1.9

2.8

2.8

2.7

Alkaline phosphatase U/L

16–200

107.7

126.1

101.5

98.1

104.4

106.1

Creatinine mg/dL

0.1–1.8

0.2

0.2

0.4

0.2

0.3

0.2

Total bilirubin mg/dL

0.3–0.7

0.2

0.2

0.3

0.3

0.2

0.2

Lactate dehydrogenase U/L

109–647

235.0

325.2

2439.8***

486.6

507.0

483.0

Blood urea nitrogen mg/dL

2–71

22.3

19.8

22.0

21.8

22.3

24.1

Cholesterol mg/dL

34–173

93.0

91.5

20.8**

92.3

80.9

56.8**

Total protein g/dL

4.6–7.3

4.0

3.7

3.6

4.8

4.7

4.6

Glucose mg/dL

60–133

286.0

297.8

104.3***

250.6

256.7

233.9

  1. **p < 0.01. ***p < 0.001.
  2. Values significantly different from the control group are highlighted in boldface.